Agape ATP Corp Form 8-K Summary
Business Context and Reporting Period
Agape ATP Corp (OTC: AATP), an emerging growth company incorporated in Nevada, filed this Current Report on May 12, 2020. The filing discloses the completion of an acquisition on May 8, 2020, wherein the Company acquired approximately 99.99% of the issued share capital of Agape Superior Living Sdn. Bhd. ("ASL"). Upon closing, ASL became a direct wholly-owned subsidiary conducting the Company's principal business activities.
Key Financial Metrics and Transaction Details
The transaction consideration totaled $1,714,003, based on the net asset carrying value of ASL as of March 31, 2020. The payment structure consisted of:
- Debt Offset: $656,495 offset against a loan receivable due from the Vendor (Mr. How Kok Choong) as of March 31, 2020.
- Equity Issuance: 162,694 shares of common stock valued at $1,057,508. This valuation was based on the Company's closing stock price of $6.50 on March 31, 2020.
- Dilution: The issued shares represent approximately 0.0432% of the total issued and outstanding shares post-transaction.
The filing does not provide specific revenue, profit, cash flow, or margin figures for the Company or ASL within the text of this report; such data is referenced in attached exhibits (Exhibit 99.1 and 99.2).
Material Changes
The primary material change is the consolidation of ASL into Agape ATP Corp's operations. The Company has entered into a Material Definitive Agreement (Share Exchange Agreement) with its CEO, Mr. How Kok Choong, who served as the Vendor. This transaction alters the Company's asset base and capital structure through the issuance of new equity and the extinguishment of a related-party receivable.
Guidance, Risks, and Unusual Items
Unregistered Securities: The 162,694 shares issued were sold pursuant to Section 4(a)(2) of the Securities Act and Regulation S. These shares are unregistered and cannot be offered or sold in the United States absent registration or an applicable exemption.
Financial Statements: Audited consolidated financial statements for ASL for the years ended December 31, 2019 and 2018, and unaudited pro forma financial information for Agape ATP Corp, are incorporated by reference in Exhibits 99.1 and 99.2 respectively. The text of this filing does not contain specific forward-looking guidance or management commentary beyond the transaction details.
Investor Verification Checklist
- Review Exhibit 99.1 for the audited financial health and liabilities of Agape Superior Living Sdn. Bhd.
- Examine Exhibit 99.2 for the unaudited pro forma financial impact of the acquisition on Agape ATP Corp.
- Verify the valuation methodology used for the stock issuance ($6.50/share) against market conditions at the time.
- Confirm the status of the $656,495 loan receivable offset and ensure proper accounting treatment for the related-party transaction.
- Check for any restrictions on the newly issued shares regarding resale or registration rights.